Clinical Trials on Cardiovascular Death in Japan

Total 1153 results

Translational Research Center for Medical Innovation...
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City...

Completed

Acarbose and Secondary Prevention After Coronary Stenting

Glucose Metabolism Disorders | Coronary Artery Disease

Japan
Novo Nordisk A/S

Completed

To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan

Congenital Bleeding Disorder | Haemophilia A

Japan
Boehringer Ingelheim

Completed

Filtered Trial for Telmisartan 40mg Non-responder

Hypertension

Japan
Kyoto University
Juntendo University; Yamaguchi University Hospital

Completed

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

Coronary Disease | Hypercholesterolemia

Japan
Pfizer

Active, not recruiting

A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies

Lymphoma | Multiple Myeloma

Japan
Stempeutics Research Pvt Ltd
Stempeutics Research Malaysia SDN BHD

Withdrawn

Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke

Stroke

Malaysia
Cordis Corporation
Quintiles, Inc.; HealthCore-NERI

Completed

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION) (INSPIRATION)

Abdominal Aortic Aneurysm

United States, Japan
National Cerebral and Cardiovascular Center
Juntendo University; Kyoto University; Kobe City General Hospital

Completed

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms (NCVC-CS1_UAN)

Intracranial Aneurysm

Japan
Kenichiro Yamagata

Completed

Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment (ULTRA-FAST)

Atrial Fibrillation | Peripheral Vascular Disease | Vascular Access Complications

Czechia, Japan
Pfizer

Active, not recruiting

MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

Japan
Foundation for Biomedical Research and Innovation
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City... and other collaborators

Terminated

Stem Cell Study for Patients With Heart Disease

Myocardial Infarction | Coronary Artery Disease | Chest Pain | Angina | Chronic Myocardial Ischemia

Japan
Janssen Pharmaceutical K.K.

Completed

An Exploratory Study of Nesiritide in Participants With Acute Heart Failure

Heart Failure, Congestive

Japan
Boston Scientific Corporation

Completed

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)

Peripheral Arterial Disease

Japan
Celgene Corporation

Terminated

Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin Lymphoma

Japan
Bristol-Myers Squibb

Completed

Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Multiple Myeloma

Japan
Celgene

Completed

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Multiple Myeloma

Japan
Osaka Acute Coronary Insufficiency Study Group

Unknown

Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study (PRACTIC)

Acute Myocardial Infarction

Japan
University of Jazan

Completed

Structured Physiotherapy Program in Obese and Non-obese Patients

Coronary Artery Disease | Obesity

Saudi Arabia
Pfizer

Completed

Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient

Hypertension

Japan
Bayer

Completed

BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status

Atrial Fibrillation

Japan
Gilead Sciences

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Follicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)

Japan
Edwards Lifesciences

Completed

PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcatheter Valve Trial (PREVAIL-20J)

Aortic Valve Stenosis

Japan
Novartis Pharmaceuticals

Completed

Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

Severe Pulmonary Arterial Hypertension

Japan
Astellas Pharma Inc

Completed

Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

Venous Thromboembolism

Japan
University of the Ryukyus

Completed

Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease (DRC-04)

Coronary Artery Disease | Inflammation | Diabetes Mellitus, Type 2 | Diarrhea | Colchicine | White Blood Cell

Japan
Medtronic Cardiac Surgery
Medtronic

Completed

PERIGON Japan Trial

Aortic Stenosis

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-2506 in Patients With Acute Ischemic Stroke

Stroke

Japan
Karthick Balasubramanian

Not yet recruiting

tDCS for Neurological Disability Among Subacute Stroke Survivors to Improve Multiple Domains in Quality of Life

Stroke | Stroke, Ischemic

Saudi Arabia
Boston Scientific Corporation

Completed

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)

Aortic Stenosis

Japan
University Hospital, Lille

Completed

Pre-stroke Cognitive Status and Thrombolytic Therapy (OPHELIE-COG)

Brain Ischemia | Dementia | Adverse Effect of Thrombolytic Drugs | Impaired Cognition

France, Japan
Yokohama City University Medical Center
Yokohama City University

Unknown

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran (RIVAL-AF)

Atrial Fibrillation

Japan
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Spain, Germany, Japan
Kitasato University
Yokohama City University Medical Center; St. Marianna University School of... and other collaborators

Unknown

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Hypertension | Type 2 Diabetes Mellitus

Japan
Novartis Pharmaceuticals

Active, not recruiting

A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

Heart Failure

Japan
Santen Pharmaceutical Co., Ltd.

Recruiting

A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension

Open Angle Glaucoma, Ocular Hypertension

Japan
International University of Health and Welfare
Japan Agency for Medical Research and Development; Chugai Pharmaceutical; Keio...

Recruiting

Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)

Pulmonary Arterial Hypertension

Japan
Idorsia Pharmaceuticals Ltd.

Terminated

Tezosentan in Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States, Japan, France
Medico's Hirata Inc.

Terminated

Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis

Severe Aortic Stenosis

Japan
Bayer

Completed

A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice (CAPTURE)

Hypertension, Pulmonary

Japan, Germany, Sweden, Colombia, Turkey, Belgium, Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients

Heart Failure

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Ottawa Heart Institute Research Corporation
GE Healthcare

Recruiting

Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

Coronary Artery Disease

Canada, Germany, Belgium, Japan, Singapore
Neonatal Encephalopathy Consortium, Japan
National Cerebral and Cardiovascular Center; Nagoya University; Tokyo Women's... and other collaborators

Completed

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Neonatal Encephalopathy | Hypoxic-ischemic Encephalopathy

Japan
Neonatal Encephalopathy Consortium, Japan
National Cerebral and Cardiovascular Center; Nagoya University; Tokyo Women's... and other collaborators

Unknown

Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)

Japan
Boehringer Ingelheim

Completed

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

Hypertension

Japan
GlaxoSmithKline

Completed

A Study to Evaluate GSK1325760A - a Long-Term Extension Study

Pulmonary Arterial Hypertension | Hypertension, Pulmonary

Japan
Takeda

Completed

A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Hereditary Angioedema

Japan
Imperial College London
McGill University; Erasmus Medical Center; Academisch Medisch Centrum - Universiteit... and other collaborators

Completed

Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam. (ASSESS-REGURGE)

Aortic Valve Insufficiency | Aortic Valve Regurgitation

Netherlands, Canada, Germany, Japan, United Kingdom
Jichi Medical University
Eli Lilly and Company; Boehringer Ingelheim

Completed

SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)

T2DM (Type 2 Diabetes Mellitus) | Nocturnal Hypertension

Japan
Janssen Pharmaceutical K.K.

Active, not recruiting

A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Japan

Clinical Trials on Cardiovascular Death in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations